Series date: 
07/01/2020 - 6:30am CDT to 12/31/2020 - 8:00am CST

Present new surgical case to ensure that the responsible MDs provide the patient with NCCN guideline appropriate are. Imaging is reviewed for each tumor to determine typical and atypical features that might influence treatment, additional factors of RCOG status and co-morbidities are also presented.

OBJECTIVES: Upon completion of this activity, the participant should be able to: 

  1. Identify the appropriate NCCN guideline-based care for patients with primary liver cancer, as well as metastatic disease.
  2. Recognize common presenting symptoms of primary and secondary liver cancer.
  3. Analyze treatment modalities applicable to patients with primary and secondary liver cancer.
  4. Interpret MRI and other imaging scans for patients with liver cancer.
  5. Review trials and new surgical techniques available for appropriate liver cancer patients in the BSWH Health System.

FACULTY DISCLOSURE: Robert Goldstein, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. 

PLANNERS DISCLOSURES: Robert Goldstein, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. 

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

For information please contact Melissa Kreston @ Melissa.Kreston@BSWHealth.org 

Series location: 
Texas Oncology-Baylor Charles A. Sammons Cancer Center
3401 Worth Street, Ste 400
Dallas, TX 75246
United States

Sessions

Session Date
20200825 Dallas Liver TB 08/25/2020 - 6:30am to 8:00am CDT
20200908 Dallas Liver TB Template 09/08/2020 - 6:30am to 8:00am CDT
20200922 Dallas Liver TB 09/22/2020 - 6:30am to 8:00am CDT
20201013 Dallas Liver TB 10/13/2020 - 6:30am to 8:00am CDT
20201027 Dallas Liver TB 10/27/2020 - 6:30am to 8:00am CDT
20201110 Dallas Liver TB 11/10/2020 - 6:30am to 8:00am CST
20201124 Dallas Liver TB 11/24/2020 - 6:30am to 8:00am CST
20201208 Dallas Liver TB 12/08/2020 - 6:30am to 8:00am CST
lpc 02/01/2021 - 1:12pm CST